Risperdal 0.5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FU193
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,855
Award facts
- Contract value 100% obligated
- $3,855.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,855.14 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on November 26, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside delivery order utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that extends through December 2026 and provides global pharmaceutical and medical supply solutions to military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal procurement capabilities as a critical vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for Risperdal, an antipsychotic medication used in treating schizophrenia and bipolar disorder, reflects the company's ongoing role in supporting Department of Defense medical supply requirements through competitive procurement on the DLA's primary pharmaceutical vendor contract.
Quick answers
Who was awarded contract SPE2DR26FU193?
SPE2DR26FU193 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU193 worth?
The government has obligated $3,855 on SPE2DR26FU193.
Is contract SPE2DR26FU193 an order under another contract?
Yes. SPE2DR26FU193 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU193 competed?
The extent of competition for SPE2DR26FU193 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award